Armata Pharmaceuticals segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Armata Pharmaceuticals utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
ARMP | Armata Pharmaceuticals | -$0.15 | -$0.50 | — | — | $2.97M | $1.38M | — | — | 11/12/2025 | |
ARMP | Armata Pharmaceuticals | -$0.25 | -$0.39 | -$0.45 | -15.38% | $0.00 | $1.38M | $2.17M | 57.17% | 08/12/2025 | |
ARMP | Armata Pharmaceuticals | -$0.69 | -$0.39 | -$0.20 | 47.37% | $966.00K | $1.38M | $491.00K | -64.42% | 05/14/2025 | |
ARMP | Armata Pharmaceuticals | -$0.55 | -$0.35 | -$0.23 | 34.29% | $1.53M | $1.56M | $1.24M | -20.83% | 03/20/2025 | |
ARMP | Armata Pharmaceuticals | -$0.86 | -$0.29 | -$0.15 | 46.43% | $1.23M | $1.13M | $2.97M | 230.33% | 11/13/2024 | |
ARMP | Armata Pharmaceuticals | -$0.17 | -$0.42 | -$0.25 | 43.18% | $980.00K | $1.15M | $0.00 | -100.00% | 08/13/2024 | |
ARMP | Armata Pharmaceuticals | -$0.40 | -$0.31 | -$0.69 | -122.58% | $796.00K | $1.10M | $966.00K | -12.18% | 05/07/2024 | |
ARMP | Armata Pharmaceuticals | -$0.29 | -$0.35 | -$0.55 | -57.14% | $1.05M | $860.00K | $1.53M | 77.67% | 03/21/2024 | |
ARMP | Armata Pharmaceuticals | -$0.24 | -$0.31 | -$0.86 | -177.42% | $1.34M | $950.00K | $1.23M | 28.95% | 11/14/2023 | |
ARMP | Armata Pharmaceuticals | -$0.26 | -$0.35 | -$0.17 | 51.43% | $1.88M | $1.50M | $980.00K | -34.67% | 08/14/2023 | |
ARMP | Armata Pharmaceuticals | -$0.30 | -$0.32 | -$0.40 | -25.00% | $1.24M | $1.78M | $796.00K | -55.28% | 05/11/2023 | |
ARMP | Armata Pharmaceuticals | -$0.23 | -$0.28 | -$0.29 | -3.57% | $989.00K | $1.67M | $1.05M | -37.07% | 03/16/2023 | |
ARMP | Armata Pharmaceuticals | -$0.21 | -$0.27 | -$0.24 | 11.11% | $1.25M | $1.64M | $1.34M | -18.41% | 11/09/2022 | |
ARMP | Armata Pharmaceuticals | -$0.25 | -$0.23 | -$0.26 | -13.04% | $1.17M | $1.11M | $1.88M | 69.64% | 08/11/2022 | |
ARMP | Armata Pharmaceuticals | -$0.27 | — | -$0.30 | — | $1.07M | — | $1.24M | — | 05/12/2022 | |
ARMP | Armata Pharmaceuticals | -$0.36 | -$0.28 | -$0.23 | 17.86% | $504.00K | $980.00K | $989.00K | 0.92% | 03/17/2022 | |
ARMP | Armata Pharmaceuticals | -$0.31 | -$0.26 | -$0.25 | 3.85% | $288.00K | $1.08M | $1.25M | 15.83% | 11/10/2021 | |
ARMP | Armata Pharmaceuticals | -$0.26 | -$0.26 | -$0.25 | 3.85% | $31.00K | — | $1.17M | — | 08/12/2021 | |
ARMP | Armata Pharmaceuticals | -$0.49 | -$0.25 | -$0.27 | -8.00% | $0.00 | — | $1.07M | — | 05/13/2021 | |
ARMP | Armata Pharmaceuticals | -$0.41 | — | -$0.36 | — | $0.00 | — | $504.00K | — | 03/18/2021 | |
ARMP | Armata Pharmaceuticals | -$0.73 | — | -$0.31 | — | $0.00 | — | $288.00K | — | 11/12/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-12 | $-0.45 | $-0.39 | -15.4 % |
Q1 | 2025-05-14 | $-0.20 | $-0.39 | 47.4 % |
Q4 | 2025-03-20 | $-0.23 | $-0.35 | 34.3 % |
Q3 | 2024-11-13 | $-0.15 | $-0.29 | 46.4 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-12 | $2.17M | $1.38M | 57.2 % |
Q1 | 2025-05-14 | $491.00K | $1.38M | -64.4 % |
Q4 | 2025-03-20 | $1.24M | $1.56M | -20.8 % |
Q3 | 2024-11-13 | $2.97M | $1.13M | 230.3 % |
Si prevede che Armata Pharmaceuticals (ARMP) fornisca risultati il novembre 12, 2025. Gli ultimi risultati sono stati pubblicati il agosto 12, 2025 per il Q2.
L'EPS effettivo era $-0.45, che mancato la stima di $-0.39.
Le entrate effettive sono state $2.2M, che superato la stima di $1.4M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.